PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), 141 Gajeongro, Yuseong, Daejeon, 34114, Republic of Korea.\', \'Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.\', \'siRNAgen Therapeutics Co., Daejeon, 34302, Republic of Korea.\', \'Hanmi Pharmaceutical Co., Hwaseong-si, Gyeonggi-do, 18536, Republic of Korea.\', \'Department of Biotechnology and Bioinformatics, College of Science and Technology, Korea University, Sejong, 30019, Republic of Korea.\', \'Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), 141 Gajeongro, Yuseong, Daejeon, 34114, Republic of Korea. mkim@krict.re.kr.\', \'Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon, 34134, Republic of Korea. mkim@krict.re.kr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-020-80896-9
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33436985
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all